# US Global Pediatric Neurology Devices Market > US Pediatric Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and By End User (hospitals & clinics, specialty center) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025-2035 - **CAGR:** 7.65% - **2018:** $ 3.57 Billion - **2024:** $ 4 Billion - **2035:** $ 9 Billion - **Key Players:** Integra LifeSciences, TheraNest, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Stryker, Johnson and Johnson, Cochlear, NeuroSigma, Biogen, Blackrock Neurotech, NeuroPace, Neurovascular, Nervilab **Report ID:** MRFR/MED/17952-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** July 13, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-global-pediatric-neurology-devices-market-19499 --- ## Market Summary ## **US Pediatric Neurology Devices Market Overview** As per MRFR analysis, the US Pediatric Neurology Devices Market Size was estimated at 3.57 (USD Billion) in 2023. The US Pediatric Neurology Devices Market Industry is expected to grow from 4(USD Billion) in 2024 to 9 (USD Billion) by 2035. The US Pediatric Neurology Devices Market CAGR (growth rate) is expected to be around 7.651% during the forecast period (2025 - 2035). ### **Key US Pediatric Neurology Devices Market Trends Highlighted** The US Pediatric Neurology Devices Market is experiencing a notable shift driven by advancements in technology and an increasing prevalence of neurological disorders. One of the key market drivers is the rise in neurodegenerative diseases such as Alzheimer's and Parkinson's. As the population ages, the demand for innovative devices that can help in early diagnosis and effective management of these conditions continues to grow. Additionally, increased funding for research and development from both private and public sectors is promoting innovation in neurology devices, contributing to market expansion. Opportunities in the US market include the development of minimally invasive devices and telemedicine solutions.The ongoing adoption of digital health technologies is transforming how healthcare providers approach treatment and monitoring of neurological conditions. This trend creates opportunities for companies to develop products that improve patient outcomes while reducing costs. Furthermore, there is a significant push towards integration of artificial intelligence in neurology devices, which can enhance diagnostic accuracy and treatment personalization. Recent trends emphasize the importance of regulatory support in speeding up product approvals. The US Food and Drug Administration has been issuing guidelines to facilitate quicker access to neurology devices for patients, encouraging market players to invest in innovative products.The increasing awareness about mental health and neurological disorders is also driving interest in therapy devices and supportive technologies aimed at improving the quality of life for affected individuals. As these trends continue to evolve, the US Pediatric Neurology Devices Market is poised for dynamic growth, enhancing the future of neurological care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Pediatric Neurology Devices Market Drivers** ### **Rising Prevalence of Neurological Disorders** The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy in the United States is a major driver for the US Pediatric Neurology Devices Market Industry. According to the Alzheimer's Association, approximately 6.2 million Americans age 65 and older are living with Alzheimer's disease in 2021, and this number is projected to rise to 12.7 million by 2050. This growing patient population enhances the demand for innovative neurology devices such as electroencephalography (EEG) devices and neuromodulation devices, which are crucial for diagnosis and treatment. Leading organizations like Medtronic and Boston Scientific are focusing on advancing technology in neurology devices to cater to this increasing market demand. Furthermore, the National Institute of Neurological Disorders and Stroke reported that nearly 1 in 6 people in the United States will have a neurological condition at some point in their lives, indicating a sustained growth potential for neurology device manufacturers. ### **Technological Advancements in Neurology Devices** The US Pediatric Neurology Devices Market Industry is significantly benefitting from rapid technological advancements in the design and functionality of neurology devices. Innovation such as the introduction of less invasive techniques and wearable monitoring devices has transformed patient care. The Food and Drug Administration has approved numerous new devices and technologies over the past few years, which has enabled better diagnosis, monitoring, and treatment of neurological disorders. A prominent example includes the approval of the NeuroPace RNS System, which was designed for epilepsy management, reflecting a trend toward precision medicine. Major manufacturers are investing heavily in Research and Development, with companies like Abbott Laboratories allocating significant proportions of their revenue to innovations that drive market growth. ### **Increased Investment in Healthcare Infrastructure** The US government and private sector investments in healthcare infrastructure play a crucial role in the growth of the US Pediatric Neurology Devices Market Industry. The Centers for Medicare and Medicaid Services have been expanding coverage for neurological services, encouraging hospitals and clinics to adopt advanced neurology devices. A notable example is the recent legislation aimed at increasing funding for mental health services and neurology care as part of the American Rescue Plan Act. This increased focus on healthcare infrastructure and patient access to quality care has stimulated demand for neurology devices. As more facilities upgrade their equipment, companies such as Siemens Healthineers and GE Healthcare are poised to benefit from rising sales in imaging and monitoring devices essential for effective neurological patient management. ### **Growing Aging Population** The demographic shift in the United States toward an older population is a significant driver for the US Pediatric Neurology Devices Market Industry. According to the U.S. Census Bureau, the population aged 65 and older is projected to reach 80 million by 2040, significantly increasing the number of individuals at risk for neurological disorders. This demographic change is leading to heightened demand for devices used in the diagnosis and treatment of age-related neurological conditions. Companies in the market are recognizing this trend and strategizing their product offerings to meet the needs of this growing segment. The advanced medical technology and functional safety standards are becoming crucial as manufacturers, including Philips Healthcare, continue to develop devices addressing the specific healthcare requirements of the elderly population. ## **US Pediatric Neurology Devices Market Segment Insights** ### **Neurology Devices Market Product Type Insights** The US Pediatric Neurology Devices Market has witnessed an expanding landscape, particularly within the Product Type segment, which reflects a diverse range of applications and innovations critical for the healthcare of the population. Neurostimulation devices play a pivotal role in managing chronic pain, neurological disorders, and mood disorders, and are increasingly embraced for their ability to enhance patient quality of life through minimally invasive techniques. As the aging population in the US continues to grow, the demand for such devices is set to rise, highlighting the significant opportunity for advancement in neurostimulation technologies to improve therapeutic outcomes. Interventional neurology is another noteworthy area within the US Pediatric Neurology Devices Market, characterized by its focus on minimally invasive surgical procedures aimed at the treatment of various neurological conditions such as stroke and vascular disorders. This segment benefits from technological advancements, including improved imaging techniques and robotic assistance, allowing for increased precision and improved patient recovery times. The growing prevalence of vascular diseases in the US population further highlights the importance of interventional neurology in addressing critical health challenges. Cerebrospinal fluid (CSF) management devices, which are essential for treating conditions that affect the flow of cerebrospinal fluid, also play a significant role in the market. These devices are crucial for patients suffering from conditions such as hydrocephalus, where the abnormal accumulation of CSF can lead to increased intracranial pressure. The increasing incidence of such neurological disorders is driving continued innovation and adoption of CSF management solutions, ensuring better long-term outcomes for patients. Neurosurgery devices encompass a range of tools employed during surgical procedures aimed at treating brain and spinal cord conditions. As advancements in surgical techniques and technologies continue to evolve, neurosurgery devices are becoming more sophisticated, allowing for less invasive procedures that are crucial for patient safety and recovery. This segment significantly benefits from the integration of enhanced imaging systems and navigational tools, improving surgical accuracy and procedural success rates. Overall, the Product Type segment within the US Pediatric Neurology Devices Market reflects a complex interplay of innovations spanning neurostimulation, interventional neurology, CSF management, and neurosurgery devices. Each niche segment is driven by distinct trends and technological advancements aimed at improving neurological health, thereby meeting the increasing demand for comprehensive treatment options within the clinical setting. The population's growing awareness of neurological disorders, combined with ongoing Research and Development, is expected to further propel market growth, making it a vital area of focus within the broader healthcare landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Neurology Devices Market End User Insights** The End User segment of the US Pediatric Neurology Devices Market is extensively categorized into hospitals and clinics, as well as specialty centers, reflecting the diverse applications of neurology devices in healthcare. Hospitals and clinics play a pivotal role in this market due to their capability to provide comprehensive patient care and access to advanced technologies which enhances the diagnosis and treatment of neurological disorders. Specialty centers are increasingly significant as well, offering focused expertise and advanced therapies specifically targeting neurological conditions. The rising prevalence of neurological diseases necessitates specialized services, leading to an increased demand for innovative devices. Trends such as technological advancements and the integration of telemedicine within these facilities are bolstering market growth. Additionally, the shift towards minimally invasive procedures and outpatient care is indicative of a fundamental transformation in the treatment paradigms, fostering greater efficiency and patient satisfaction. As neurology continues to evolve, these end users emerge as essential contributors to the US Pediatric Neurology Devices Market, adapting to meet the complexities of neurological care in an ever-growing landscape. ## **US Pediatric Neurology Devices Market Key Players and Competitive Insights** The US Pediatric Neurology Devices Market is characterized by a rapidly evolving landscape marked by advancements in technology, a focus on patient-centric solutions, and the increasing prevalence of neurological disorders. Competition within this market is fierce, driven by the need for innovative treatments and diagnostic tools that can improve patient outcomes. Companies are fostering collaborations with healthcare providers and engaging in strategic partnerships to enhance their market positions. Key factors influencing this competition include the regulatory environment, reimbursement policies, and ongoing research and development initiatives aimed at addressing unmet medical needs. Market stakeholders are also paying attention to shifting consumer preferences towards minimally invasive procedures and the integration of digital health technologies, which significantly impact product development and marketing strategies. Integra LifeSciences has established a significant presence within the US Pediatric Neurology Devices Market, leveraging its extensive expertise in neurosurgery and neurocritical care. Known for its innovative neurocritical care solutions and surgical products, Integra LifeSciences has focused on developing high-quality devices that enhance surgical precision and safety. The company’s strength lies in its strong research and development pipeline, which enables it to introduce cutting-edge products that align with evolving clinical practices. Furthermore, the robust distribution network and committed customer service have solidified its position in the market, allowing Integra LifeSciences to respond effectively to the needs of healthcare professionals and institutions across the United States. TheraNest operates within the US Pediatric Neurology Devices Market, offering a range of products and services aimed at improving clinical efficiency in mental health and neurological therapy settings. The company focuses on providing robust solutions that enhance data management and treatment accessibility for practitioners. TheraNest's key offerings include software solutions designed to streamline patient management and documentation, reflecting its commitment to supporting healthcare providers in delivering efficient care. The company has strengthened its market presence through strategic partnerships and acquisitions that allow it to expand its portfolio and enhance service delivery. TheraNest’s emphasis on user-friendly technology and integration capabilities has positioned it well amidst its competitors, making it a noteworthy entity in the realm of neurological devices tailored for the US market. ### **Key Companies in the US Pediatric Neurology Devices Market Include** ## **US Pediatric Neurology Devices Market Industry Developments** The US Pediatric Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development. Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain. The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson. This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States. ## **US Pediatric Neurology Devices Market Segmentation Insights** ### **Neurology Devices Market Product Type Outlook** ### **Neurology Devices Market End User Outlook** ## Market Drivers ### Continuous Innovation in Pediatric Neurology Technologies Rapid technological advancements in pediatric neurology devices are significantly driving market expansion in the United States. Manufacturers are introducing AI-enabled diagnostic systems, minimally invasive surgical devices, advanced neurostimulation technologies, and high-resolution neuroimaging solutions designed specifically for pediatric patients. These innovations improve diagnostic accuracy, reduce procedural risks, and enhance treatment outcomes while shortening recovery times. Increased investments in neurological research, rising collaborations between medical device companies and healthcare institutions, and growing regulatory support for innovative pediatric medical technologies are accelerating product development and commercialization, strengthening the long-term growth prospects of the US pediatric neurology devices market. ### Increasing Prevalence of Pediatric Neurological Disorders The rising incidence of pediatric neurological disorders is a major driver of the US pediatric neurology devices market. Conditions such as epilepsy, cerebral palsy, hydrocephalus, traumatic brain injuries, and neurodevelopmental disorders are becoming increasingly common, creating sustained demand for advanced diagnostic and therapeutic devices. Early diagnosis and timely intervention have become healthcare priorities, prompting hospitals and specialty pediatric centers to invest in innovative neurology equipment. Growing awareness among parents, improved access to specialized neurological care, and favorable government initiatives supporting pediatric healthcare are further contributing to market growth by increasing the adoption of advanced pediatric neurology devices across the United States. ## Segment Insights ### Neurology Devices Market Product Type Insights The US Pediatric Neurology Devices Market has witnessed an expanding landscape, particularly within the Product Type segment, which reflects a diverse range of applications and innovations critical for the healthcare of the population. [Neurostimulation devices](https://www.marketresearchfuture.com/reports/neurostimulation-devices-market-2263)play a pivotal role in managing chronic pain, neurological disorders, and mood disorders, and are increasingly embraced for their ability to enhance patient quality of life through minimally invasive techniques. As the aging population in the US continues to grow, the demand for such devices is set to rise, highlighting the significant opportunity for advancement in neurostimulation technologies to improve therapeutic outcomes. Interventional neurology is another noteworthy area within the US Pediatric Neurology Devices Market, characterized by its focus on minimally invasive surgical procedures aimed at the treatment of various neurological conditions such as stroke and vascular disorders. This segment benefits from technological advancements, including improved imaging techniques and robotic assistance, allowing for increased precision and improved patient recovery times. The growing prevalence of vascular diseases in the US population further highlights the importance of interventional neurology in addressing critical health challenges. Cerebrospinal fluid (CSF) management devices, which are essential for treating conditions that affect the flow of cerebrospinal fluid, also play a significant role in the market. These devices are crucial for patients suffering from conditions such as hydrocephalus, where the abnormal accumulation of CSF can lead to increased intracranial pressure. The increasing incidence of such neurological disorders is driving continued innovation and adoption of CSF management solutions, ensuring better long-term outcomes for patients. ### Neurology Devices Market End User Insights The End User segment of the US Pediatric Neurology Devices Market is extensively categorized into hospitals and clinics, as well as specialty centers, reflecting the diverse applications of neurology devices in healthcare. Hospitals and clinics play a pivotal role in this market due to their capability to provide comprehensive patient care and access to advanced technologies which enhances the diagnosis and treatment of neurological disorders. Specialty centers are increasingly significant as well, offering focused expertise and advanced therapies specifically targeting neurological conditions. The rising prevalence of neurological diseases necessitates specialized services, leading to an increased demand for innovative devices. Trends such as technological advancements and the integration of telemedicine within these facilities are bolstering market growth. Additionally, the shift towards minimally invasive procedures and outpatient care is indicative of a fundamental transformation in the treatment paradigms, fostering greater efficiency and patient satisfaction. As neurology continues to evolve, these end users emerge as essential contributors to the US Pediatric Neurology Devices Market, adapting to meet the complexities of neurological care in an ever-growing landscape. ## Competitive Benchmarking The US Pediatric Neurology Devices Market is characterized by a rapidly evolving landscape marked by advancements in technology, a focus on patient-centric solutions, and the increasing prevalence of neurological disorders. Competition within this market is fierce, driven by the need for innovative treatments and diagnostic tools that can improve patient outcomes. Companies are fostering collaborations with healthcare providers and engaging in strategic partnerships to enhance their market positions. Key factors influencing this competition include the regulatory environment, reimbursement policies, and ongoing research and development initiatives aimed at addressing unmet medical needs. Market stakeholders are also paying attention to shifting consumer preferences towards minimally invasive procedures and the integration of digital health technologies, which significantly impact product development and marketing strategies. Integra LifeSciences has established a significant presence within the US Pediatric Neurology Devices Market, leveraging its extensive expertise in neurosurgery and neurocritical care. Known for its innovative neurocritical care solutions and surgical products, Integra LifeSciences has focused on developing high-quality devices that enhance surgical precision and safety. The company’s strength lies in its strong research and development pipeline, which enables it to introduce cutting-edge products that align with evolving clinical practices. Furthermore, the robust distribution network and committed customer service have solidified its position in the market, allowing Integra LifeSciences to respond effectively to the needs of healthcare professionals and institutions across the United States. TheraNest operates within the US Pediatric Neurology Devices Market, offering a range of products and services aimed at improving clinical efficiency in mental health and neurological therapy settings. The company focuses on providing robust solutions that enhance data management and treatment accessibility for practitioners. TheraNest's key offerings include software solutions designed to streamline patient management and documentation, reflecting its commitment to supporting healthcare providers in delivering efficient care. The company has strengthened its market presence through strategic partnerships and acquisitions that allow it to expand its portfolio and enhance service delivery. TheraNest’s emphasis on user-friendly technology and integration capabilities has positioned it well amidst its competitors, making it a noteworthy entity in the realm of neurological devices tailored for the US market. ## Recent News & Developments The US Pediatric Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development. Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain. The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson. This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States. ## Report Scope | Report Attribute/Metric Source: | Details | | --- | --- | | MARKET SIZE 2018 | 3.57(USD Billion) | | MARKET SIZE 2024 | 4.0(USD Billion) | | MARKET SIZE 2035 | 9.0(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.651% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | MARKET FORECAST PERIOD | 2025 - 2035 | | HISTORICAL DATA | 2019 - 2024 | | MARKET FORECAST UNITS | USD Billion | | KEY COMPANIES PROFILED | Integra LifeSciences, TheraNest, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Stryker, Johnson and Johnson, Cochlear, NeuroSigma, Biogen, Blackrock Neurotech, NeuroPace, Neurovascular, Nervilab | | SEGMENTS COVERED | Product Type, End User | | KEY MARKET OPPORTUNITIES | Telemedicine integration for patient care, Advanced neuroimaging technologies development, Wearable brain monitoring devices, Robotics in neurosurgery applications, Digital therapeutics for neurological disorders | | KEY MARKET DYNAMICS | Technological advancements, Aging population, Increasing prevalence of neurological disorders, Growing demand for minimally invasive procedures, Rising healthcare expenditure | | COUNTRIES COVERED | US | --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-global-pediatric-neurology-devices-market-19499*